IL6 and Miyoshi myopathy: In MM, delivery of miR-146a to BMSCs has been demonstrated to activate the expression of pro-tumorigenic cytokines IL-6 and CXCL1 in a gamma-secretase dependent manner (De Veirman et al., 2016).